Target intelligence / Profile preview

TNS2 antisense RNA 1 (TNS2-AS1)

Target: TNS2-AS1
Molecular classification: Long non-coding RNA (lncRNA), Antisense RNA

Overview

TNS2 antisense RNA 1 (TNS2-AS1) is a human long non-coding RNA transcribed antisense to the tensin 2 (TNS2) gene. As an antisense lncRNA, it may regulate its sense gene (TNS2) via modulation of mRNA stability, chromatin structure, transcriptional regulation, and other post-transcriptional mechanisms typical of antisense lncRNAs. While the biological function of TNS2-AS1 itself has not been experimentally characterized in detail, its classification suggests a role in fine-tuning TNS2 gene expression, potentially impacting cellular processes related to migration, adhesion, and tumorigenesis regulated by TNS2. No direct involvement as a therapeutic target, clinical biomarker, or drug interaction has been reported for TNS2-AS1 as of current knowledge. If the query was intended to refer to the protein-coding gene tensin 2 (TNS2), that is a distinct entity (a focal adhesion protein involved in migration and tumor suppression in some cancers) and not the non-coding RNA TNS2-AS1.

Other names: RP11-983P16.4TNS2-AS1

Biological functions

Likely to regulate the expression of the TNS2 gene by antisense mechanisms, potentially involved in gene expression regulation and chromatin modification, as is typical for other antisense lncRNAsModulation of mRNA stability of TNS2Chromatin structure modulation related to TNS2Transcriptional regulation of TNS2Post-transcriptional mechanisms affecting TNS2

Disease associations

OtherAntisense lncRNAs frequently participate in cancer biology and gene regulation

Beyond the preview

Go deeper on TNS2 antisense RNA 1 (TNS2-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TNS2 antisense RNA 1 (TNS2-AS1).

Explore the full profile